adenocarcinoma in situ
Information
- Disease name
- adenocarcinoma in situ
- Disease ID
- DOID:4943
- Description
- "An in situ carcinoma that derives_from epithelial cells of glandular origin." [url:https\://www.cancer.gov/publications/dictionaries/cancer-terms/def/adenocarcinoma-in-situ]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02937155 | Active, not recruiting | In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer? | November 2016 | September 2024 | |
| NCT05613283 | Active, not recruiting | Primary Cervical Cancer Screening by Self-sampling HPV Test | November 19, 2022 | August 31, 2027 | |
| NCT01544478 | Completed | Phase 4 | V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) | November 25, 2011 | August 27, 2016 |
| NCT03546842 | Completed | Phase 3 | Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) | June 29, 2018 | January 29, 2019 |
| NCT04755517 | Enrolling by invitation | N/A | Effectiveness of Cervical Screening in Unvaccinated, Herd Effect Protected Women (HPV400) | June 9, 2020 | December 31, 2025 |
| NCT05210348 | Unknown status | Clinical Evaluation of Detection of High Risk HPV in Urine | September 15, 2021 | May 1, 2022 |
- Disase is a (Disease Ontology)
- DOID:8719
- Cross Reference ID (Disease Ontology)
- ICDO:8140/2
- Cross Reference ID (Disease Ontology)
- MESH:D065311
- Cross Reference ID (Disease Ontology)
- NCI:C4123
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:51642000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0334276
- MeSH unique ID (MeSH (Medical Subject Headings))
- D065311